Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Heck J, Stichtenoth DO, Mettin R, Jöckel J, Bickel C, Krichevsky B. Remdesivir-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE)? A case report with review of the literature. Eur J Clin Pharmacol 2020;77:141-144. [PMID: 32761371 PMCID: PMC7406697 DOI: 10.1007/s00228-020-02955-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2020] [Accepted: 07/03/2020] [Indexed: 11/25/2022]

For:	Heck J, Stichtenoth DO, Mettin R, Jöckel J, Bickel C, Krichevsky B. Remdesivir-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE)? A case report with review of the literature. Eur J Clin Pharmacol 2020;77:141-144. [PMID: 32761371 PMCID: PMC7406697 DOI: 10.1007/s00228-020-02955-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2020] [Accepted: 07/03/2020] [Indexed: 11/25/2022]

Number

Cited by Other Article(s)

Escolà H, March-Rodriguez A, Pujol RM. Symmetrical drug-related intertriginous and flexural exanthema-like rash related to severe acute respiratory syndrome coronavirus 2 infection. Indian J Dermatol Venereol Leprol 2023;89:119-121. [PMID: 36331827 DOI: 10.25259/ijdvl_355_2022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2022] [Accepted: 07/01/2022] [Indexed: 11/06/2022]

Çakıcı ÖA, Güder S, Salman A, Ergun T. Symmetrical drug-related intertriginous and flexural exanthema-like eruption: An addition to the spectrum of coronavirus disease 2019-related cutaneous findings. Indian J Dermatol Venereol Leprol 2022;88:814-816. [PMID: 36332096 DOI: 10.25259/ijdvl_165_2022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2022] [Accepted: 05/01/2022] [Indexed: 02/03/2023]

Balasubramanian P, Laldinthari C, Lalnunpuia R. Mucocutaneous adverse effects of remdesivir and favipiravir in patients with Covid-19 infection: A systematic review. INDIAN JOURNAL OF DERMATOPATHOLOGY AND DIAGNOSTIC DERMATOLOGY 2022. [DOI: 10.4103/ijdpdd.ijdpdd_70_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open

Multiple drugs. REACTIONS WEEKLY 2021. [PMCID: PMC7892721 DOI: 10.1007/s40278-021-91371-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]

Kow CS, Aldeyab M, Hasan SS. Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19. Eur J Clin Pharmacol 2020;77:435-437. [PMID: 33011825 PMCID: PMC7532950 DOI: 10.1007/s00228-020-03008-6] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [MESH Headings] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2020] [Accepted: 09/23/2020] [Indexed: 11/26/2022]